The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Chouinard, G.
* Articles by Jones, B. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Chouinard, G.
* Articles by Jones, B. D.

Am J Psychiatry 1980; 137:16-21
Copyright © 1980 by American Psychiatric Association


REGULAR ARTICLES

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

G Chouinard and BD Jones

Tardive dyskinesia is thought to result from neostriatal dopaminergic receptor supersensitivity induced by chronic treatment with neuroleptics. The authors suggest that dopaminergic supersensitivity also occurs in the mesolimbic region after chronic neuroleptic exposure, resulting in the development of a supersensitivity psychosis. Neuroleptic-induced supersensitivity psychosis is illustrated by data from 10 patients that demonstrate the syndrome's clinical and pharmacologic characteristics. An implication of neuroleptic-induced mesolimbic supersensitivity is that the tenaency toward psychotic relapse in such patients is determined by more than just the normal course of the illness.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
A.-N. Samaha, P. Seeman, J. Stewart, H. Rajabi, and S. Kapur
"Breakthrough" Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time
J. Neurosci., March 14, 2007; 27(11): 2979 - 2986.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
G. Chouinard
The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Focus, September 1, 2006; 4(4): 528.
[Full Text] [PDF]


Home page
Research on Social Work PracticeHome page
J. R. Bola
Psychosocial Acute Treatment in Early-Episode Schizophrenia Disorders
Research on Social Work Practice, May 1, 2006; 16(3): 263 - 275.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
D. E. ROSS
Clozapine and Typical Antipsychotics
Am J Psychiatry, October 1, 2004; 161(10): 1925 - 1926.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. Tranter and D. Healy
Neuroleptic discontinuation syndromes
J Psychopharmacol, January 1, 1998; 12(4): 401 - 406.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. A. Lieberman, D. Jody, J. Ma. J. Alvir, M. Ashtari, D. L. Levy, B. Bogerts, G. Degreef, D. I. Mayerhoff, and T. Cooper
Brain Morphology, Dopamine, and Eye-Tracking Abnormalities in First-Episode Schizophrenia: Prevalence and Clinical Correlates
Arch Gen Psychiatry, May 1, 1993; 50(5): 357 - 368.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. T. Gualtieri, S. R. Schroeder, R. E. Hicks, and D. Quade
Tardive Dyskinesia in Young Mentally Retarded Individuals
Arch Gen Psychiatry, April 1, 1986; 43(4): 335 - 340.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Gardos, J. O. Cole, R. M. Rapkin, R. A. LaBrie, E. Baquelod, P. Moore, R. Sovner, and J. Doyle
Anticholinergic Challenge and Neuroleptic Withdrawal: Changes in Dyskinesia and Symptom Measures
Arch Gen Psychiatry, November 1, 1984; 41(11): 1030 - 1035.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1980 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org